Search bioRxiv⌕ Search

Biology subjects

Davidovich, A.

Publications and source records attributed to Davidovich, A..

2 recordsLinked to original sources

Shared molecular consequences of epigenetic machinery disruption in neuronal progenitors

The Mendelian disorders of the epigenetic machinery (MDEMs) are an emerging cause of intellectual disability and growth abnormalities, which commonly disrupt hippocampal function. To investigate consequences of epigenetic machinery (EM) disruption during neurodevelopment, we systematically knocked out (KO) EM factors in neuronal progenitors isolated from the murine hippocampus and established a neurodifferentiation model to interrogate their functions. We then profiled gene expression and DNA methylation (DNAm) in the EM-KOs using RNA sequencing and Nanopore long-read DNA sequencing. While Dnmt1-KO induced extensive DNAm alterations, Kmt2a-KO had little effect on methylation. Nevertheless, the disruption of Kmt2a and Dnmt1 produced strikingly convergent transcriptional changes. Loss of either EM factor led to premature neuronal differentiation, partially explaining this convergence, and MYC appeared as a shared regulatory node linked to downregulation of cell-cycle programs in these cells. Extending our methylation analysis to 46 EM genes, we found that loss of DNA methyltransferases induced the strongest DNAm changes, whereas other EM-KOs had subtle or negligible effects. However, clustering of EM-KOs based on promoter DNAm levels revealed three distinct EM subgroups, of which two were enriched for interactions with the DNAm machinery. Allele-specific analysis of DNAm further identified a single differentially methylated region shared across the 46 EM-KOs, localized to the FVB allele over the Zic4 3UTR. Furthermore, Zic4 overexpression appears to maintain the neuronal progenitor state, suggesting functional relevance of this locus. Taken together, our results reveal both gene-specific and convergent effects across diverse EM-KOs and provide new insight into the molecular etiology of the MDEMs.

genomics↗

Precision pharmacological reversal of genotype-specific diet-induced metabolic syndrome in mice informed by transcriptional regulation

Diet-related metabolic syndrome is the largest contributor to adverse health in the United States. However, the study of gene-environment interactions and their epigenomic and transcriptomic integration is complicated by the lack of environmental and genetic control in humans that is possible in mouse models. Here we exposed three mouse strains, C57BL/6J (BL6), A/J, and NOD/ShiLtJ (NOD), to a high-fat high-carbohydrate diet, leading to varying degrees of metabolic syndrome. We then performed transcriptomic and genomic DNA methylation analyses and found overlapping but also highly divergent changes in gene expression and methylation upstream of the discordant metabolic phenotypes. Strain-specific pathway analysis of dietary effects reveals a dysregulation of cholesterol biosynthesis common to all three strains but distinct regulatory networks driving this dysregulation. This suggests a strategy for strain-specific targeted pharmacologic intervention of these upstream regulators informed by transcriptional regulation. As a pilot study, we administered the drug GW4064 to target one of these genotype-dependent networks, the Farnesoid X receptor pathway, and found that GW4064 exerts genotype-specific protection against dietary effects in BL6, as predicted by our transcriptomic analysis, as well as increased inflammatory-related gene expression changes in NOD. This pilot study demonstrates the potential efficacy of precision therapeutics for genotype-informed dietary metabolic intervention, and a mouse platform for guiding this approach.

genetics↗